ES2097142T3 - Derivados de indol, su preparacion y medicamento que los contiene destinado para la prevencion y para el tratamiento de la nefritis. - Google Patents

Derivados de indol, su preparacion y medicamento que los contiene destinado para la prevencion y para el tratamiento de la nefritis.

Info

Publication number
ES2097142T3
ES2097142T3 ES90902836T ES90902836T ES2097142T3 ES 2097142 T3 ES2097142 T3 ES 2097142T3 ES 90902836 T ES90902836 T ES 90902836T ES 90902836 T ES90902836 T ES 90902836T ES 2097142 T3 ES2097142 T3 ES 2097142T3
Authority
ES
Spain
Prior art keywords
nephritis
prevention
treatment
indol
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90902836T
Other languages
English (en)
Inventor
Hitoshi Tone
Seiji Sato
Hideaki Sato
Katsumi Tamura
Shigeharu Tamada
Kazumi Mezon Yamato Kondo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2014551A external-priority patent/JP2523383B2/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2097142T3 publication Critical patent/ES2097142T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

ESTE INVENTO RELATA DERIVADOS INDOLICOS DE LA FORMULA GENERAL (1) Y SUS SALES; UN METODO PARA PREPARAR EL MISMO; Y SUS APLICACIONES EN LA PREVENCION Y EL TRATAMIENTO DE LA NEFRITIS; EN DONDE R REPRESENTA HIDROGENO, CIANO O UNO DE OTROS VARIOS SUSTITUYENTES; 1 ES UN ENTERO DE 1 O 2; R1 REPRESENTA HIDROGENO, UNO DE VARIOS SUSTITUYENTES O UN GRUPO DE LA FORMULA (2), (EN DONDE A REPRESENTA UN ENLACE SIMPLE, -CH(OH)-, -CH=, -C(=O) O ALQUIL; Y R2,R3,R4,R5 Y R6 CADA UNO REPRESENTAN UNO DE VARIOS SUSTITUYENTES), Y Z REPRESENTA HIDROGENO O UN GRUPO DE FORMULA (2) PROVISTO QUE R1 REPRESENTA UN GRUPO DE FORMULA (2) CUANDO Z REPRESENTA HIDROGENO.
ES90902836T 1989-02-10 1990-02-09 Derivados de indol, su preparacion y medicamento que los contiene destinado para la prevencion y para el tratamiento de la nefritis. Expired - Lifetime ES2097142T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP3157989 1989-02-10
JP01199771 1989-07-31
JP01234978 1989-09-11
JP2014551A JP2523383B2 (ja) 1990-01-23 1990-01-23 Ｎｆ―１６１６―９０４物質の製造法

Publications (1)

Publication Number Publication Date
ES2097142T3 true ES2097142T3 (es) 1997-04-01

Family

ID=27456222

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90902836T Expired - Lifetime ES2097142T3 (es) 1989-02-10 1990-02-09 Derivados de indol, su preparacion y medicamento que los contiene destinado para la prevencion y para el tratamiento de la nefritis.

Country Status (6)

Country Link
EP (1) EP0411150B1 (es)
KR (1) KR910700250A (es)
DE (1) DE69029231T2 (es)
DK (1) DK0411150T3 (es)
ES (1) ES2097142T3 (es)
WO (1) WO1990009380A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5591761A (en) * 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5594021A (en) * 1993-05-20 1997-01-14 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US5571821A (en) * 1993-05-20 1996-11-05 Texas Biotechnology Corporation Sulfonamides and derivatives thereof that modulate the activity of endothelin
US5736509A (en) * 1990-12-14 1998-04-07 Texas Biotechnology Corporation Cyclic peptide surface feature mimics of endothelin
WO1993023404A1 (en) * 1992-05-19 1993-11-25 Immunopharmaceutics, Inc. Compounds that modulate endothelin activity
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
JPH0725858A (ja) * 1993-07-13 1995-01-27 Otsuka Pharmaceut Co Ltd ピペラジン誘導体
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
US5883098A (en) * 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
WO1996037489A1 (en) * 1995-05-25 1996-11-28 Fujisawa Pharmaceutical Co., Ltd. 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
US5977117A (en) 1996-01-05 1999-11-02 Texas Biotechnology Corporation Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
US5958905A (en) 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US5804585A (en) 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
US6432994B1 (en) 1997-04-28 2002-08-13 Texas Biotechnology Corporation Sulfonamides for treatment of endothelin-mediated disorders
US5783705A (en) 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
WO2001032621A1 (en) * 1999-10-29 2001-05-10 Wakunaga Pharmaceutical Co., Ltd. Novel indole derivatives and drugs containing the same as the active ingredient
EP1626965A1 (en) * 2003-05-09 2006-02-22 Pharmacia & Upjohn Company LLC Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
WO2005073180A1 (ja) * 2003-12-25 2005-08-11 Kureha Corporation ヒドロキサム酸誘導体、及び該誘導体を含むａｇｅ生成阻害剤
CN113480524B (zh) * 2021-08-10 2022-08-30 河北工业大学 生物碱hamacanthins系列衍生物及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3259622A (en) * 1962-09-07 1966-07-05 Merck & Co Inc 1-benzyl-3-indolyl-alpha-haloalkyl and alkylidenyl acetic acids
DE3132882A1 (de) * 1981-08-20 1983-03-03 Cassella Ag, 6000 Frankfurt Neue piperazinone, ihre herstellung und verwendung
GB8427735D0 (en) * 1984-11-02 1984-12-12 Fujisawa Pharmaceutical Co Piperazine compound
JPS63200928A (ja) 1987-02-16 1988-08-19 Mekanitsukushiya:Kk 半自動ネジ締め機
ES2054748T3 (es) 1987-08-11 1994-08-16 Otsuka Pharma Co Ltd Un procedimiento para proporcionar un compuesto de pirazinoxido.

Also Published As

Publication number Publication date
KR910700250A (ko) 1991-03-14
WO1990009380A1 (fr) 1990-08-23
EP0411150A4 (en) 1992-03-11
DE69029231T2 (de) 1997-03-20
DK0411150T3 (da) 1996-12-16
EP0411150B1 (en) 1996-11-27
EP0411150A1 (en) 1991-02-06
DE69029231D1 (de) 1997-01-09

Similar Documents

Publication Publication Date Title
MX9303770A (es) Derivados de alquilamino ramificados de tiazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
PE10290A1 (es) Procedimiento de preparacion de derivados de benzotriazol
ES2039369T3 (es) Un procedimiento para la produccion de nuevos derivados de acido picolinico.
AR004219A1 (es) Nuevos derivados de quinazolina, procedimientos para su preparacion, composiciones que los contienen y su uso en la preparacion de medicamentos,particularmente en el tratamiento de trastornos inflamatorios
ES2040276T3 (es) Derivados de la indolizina, procedimiento para su preparacion y composiciones que los contienen.
ES2056962T3 (es) Un procedimiento para la preparacion de nuevos derivados de camptotecina.
ES2117035T3 (es) Derivados antiproliferativos del 4-h-nafto(1,2-b)pirano.
AR005229A1 (es) Un derivado de 2,3-dioxo-1,2,3,4-tetrahidro-quinoxaliil y una composicion farmaceutica que lo comprende.
DK0564350T3 (da) 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning
ES2099755T3 (es) Derivados tripeptidicos de trifluorometilcetona.
UA41869C2 (uk) Похідні етаноламіну, спосіб їх одержання, фармацевтична композиція, спосіб лікування
MX9205817A (es) Derivados de benzodiazepina, procedimiento para supreparacion y medicamentos que los contienen
DK55584A (da) Hidtil ukendte carbacykliner, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
ES2039361T3 (es) Derivados de 3-vinil- y 3-etinil-beta-carbolinas, su preparacion y su utilizacion como medicamentos.
ES2058177T3 (es) Nuevos derivados de alcanosulfonanilida, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
ES2116467T3 (es) Derivados de 5h,10h-imidazo(1,2-a)indeno(1,2-e)pirazina-4-ona, su preparacion y los medicamentos que les contienen.
ES2057802T3 (es) Nuevos derivados de 3-amino-cromano, procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES455741A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,3-bencenodimetanol.
AR240859A2 (es) Composicion herbicida que contiene un derivado de difenil eter, dicho compuesto y procedimiento paraprepararlo
DK212387A (da) Benzhydrylpiperazinderivater eller farmaceutisk acceptable syreadditonssalte og kvaternaere ammoni-umsalte deraf, deres fremstilling og anvendelse
ES2108897T3 (es) Compuesto del tipo oxima eter, procesos para su preparacion y fungicida que contiene dicho compuesto.
FI73983B (fi) Foerfarande foer framstaellning av som antidepressiva medel anvaendbara 2-piperazinyl-4-fenylkinazoliner.
DK0658557T3 (da) Eburnan-derivater, fremgangsmåde til fremstilling af sådanne derivater og farmaceutiske sammensætninger indeholdende disse
ES464013A1 (es) Procedimiento para preparar derivados sustituidos de orto- fenilendiamina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 411150

Country of ref document: ES